2012 -
2018 Founder, Chairman and CEO @ Mabspace Biosciences
2012 -
2013 Consultant @ Shenogen Pharma Group
2010 -
2012 SVP and Head, Research and Development; @ Shenogen Pharma Group
2005 -
2010 Principal Scientist @
2000 -
2005 Senior Reseach Scientist @
1997 -
2000 Postdoc Fellow @
Xueming Qian Education
Albany Medical College
Ph.D. (Neuroscience and Pharmacology)
1995
-
1997
The Rockefeller University
Molecular Neuroscience
1992
-
1995
Columbia University Vagelos College of Physicians and Surgeons
M.A. (Neuroscience / Physiology)
1990
-
1992
Fudan University
B.S. (Biophysics)
1985
-
1990
Xueming Qian Skills
Molecular Biology
Drug Discovery
Cancer
Cell
Therapeutics
Assay Development
Drug Development
Antibodies
Neuroscience
Genomics
Stem Cells
Laboratory
Technology Transfer
Biopharmaceuticals
Biochemistry
Clinical Trials
Small Molecules
GLP
Biotechnology
Oncology
Biomarker Discovery
Protein Chemistry
Commercialization
Clinical Development
Cell Culture
Immunology
Inflammation
Cell Biology
CRO
Purification
Biologics
In Vivo
Pharmaceutical Industry
Life Sciences
Research and Development (R&D)
Monoclonal Antibodies
Cell Based Assays
Strategy
Teaching
Research and Development R&d
Research and Development
Xueming Qian Summary
Xueming Qian, based in Princeton, NJ, US, is currently a Founder, Chairman and CEO at Transcenta. Xueming Qian brings experience from previous roles at Transcenta, Mabspace Biosciences and Shenogen Pharma Group. Xueming Qian holds a 1995 - 1997 Ph.D. in Neuroscience and Pharmacology @ Albany Medical College. With a robust skill set that includes Molecular Biology, Drug Discovery, Cancer, Cell, Therapeutics and more. Xueming Qian has 2 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.